PML: The Dark Side of Immunotherapy in Multiple Sclerosis. Warnke C, Olsson T, Hartung H-P Trends Pharmacol Sci. 2015 Oct 20. PMID: 26497099. Abstract CommentRecommendBookmarkWatch